FDAnews Drug Daily Bulletin

Irish Drugmaker Elan to Spin Off Research Unit

Aug. 14, 2012
A A
The decision to split the company comes hard on the heels of the failure of an experimental Alzheimer’s drug being developed with Pfizer and Johnson & Johnson, although Chief Executive Kelly Martin said it had been planned for more than a year.
Reuters